{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:13Z","timestamp":1786123333213,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>In cardiac surgery, pulmonary hypertension is an important prognostic factor for which several treatments have been suggested over time. In this systematic review and meta-analysis, we compared the efficacy of inhaled aerosolized vasodilators to intravenously administered agents and to placebo in the treatment of pulmonary hypertension during cardiac surgery. We searched MEDLINE, CENTRAL, EMBASE, Web of Science, and clinicaltrials.gov databases from inception to October 2015. The incidence of mortality was assessed as the primary outcome. Secondary outcomes included length of stay in hospital and in the intensive care unit, and evaluation of the hemodynamic profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Of the 2897 citations identified, 10 studies were included comprising a total of 434 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Inhaled aerosolized agents were associated with a significant decrease in pulmonary vascular resistance (\u221241.36 dyne\u00b7s\/cm\n                      <jats:sup>5<\/jats:sup>\n                      ,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .03) and a significant increase in mean arterial pressure (8.24 mm Hg,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .02) and right ventricular ejection fraction (7.29%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001) when compared to intravenously administered agents. No significant hemodynamically meaningful differences were observed between inhaled agents and placebo; however, an increase in length of stay in the intensive care unit was shown with the use of inhaled aerosolized agents (0.66 days,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .01). No other differences were observed for either comparison.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The administration of inhaled aerosolized vasodilators for the treatment of pulmonary hypertension during cardiac surgery is associated with improved right ventricular performance when compared to intravenously administered agents. This review does not support any benefit compared to placebo on major outcomes. Further investigation is warranted in this area of research and should focus on clinically significant outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000002138","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T12:50:14Z","timestamp":1497012614000},"page":"393-402","source":"Crossref","is-referenced-by-count":56,"title":["Aerosolized Vasodilators for the Treatment of Pulmonary Hypertension in Cardiac Surgical Patients: A Systematic Review and Meta-analysis"],"prefix":"10.1213","volume":"125","author":[{"given":"Mahsa","family":"Elmi-Sarabi","sequence":"first","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Deschamps","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Delisle","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosham","family":"Ased","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Haddad","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoan","family":"Lamarche","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis P.","family":"Perrault","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lambert","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis F.","family":"Turgeon","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Y.","family":"Denault","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II.","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/j.cjca.2011.07.315","article-title":"New intensive care risk score to predict mortality after cardiac surgery.","volume":"27","author":"Lamarche","year":"2011","journal-title":"Can J Cardiol"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1213\/00000539-199810000-00013","article-title":"Pulmonary hypertension and major surgery.","volume":"87","author":"Rodriguez","year":"1998","journal-title":"Anesth Analg"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157340310790231671","article-title":"Pulmonary hypertension in cardiac surgery.","volume":"6","author":"Denault","year":"2010","journal-title":"Curr Cardiol Rev"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCC.0b013e32834a7619","article-title":"Pulmonary hypertension in critical care.","volume":"17","author":"Gayat","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0003-4975(95)00408-D","article-title":"Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations.","volume":"60","author":"Goldman","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00000542-199506000-00001","article-title":"Aerosolized prostacyclin. In search of the ideal pulmonary vasodilator.","volume":"82","author":"Wetzel","year":"1995","journal-title":"Anesthesiology"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.aco.0000192765.27453.5a","article-title":"Treatment of pulmonary hypertension with selective pulmonary vasodilators.","volume":"19","author":"Haj","year":"2006","journal-title":"Curr Opin Anaesthesiol"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMp1611755","article-title":"Regulating off-label promotion\u2014a critical test.","volume":"375","author":"Robertson","year":"2016","journal-title":"N Engl J Med"},{"key":"R10-20230812","first-page":"356982","article-title":"Perioperative anesthesiological management of patients with pulmonary hypertension.","volume":"2012","author":"Gille","year":"2012","journal-title":"Anesthesiol Res Pract"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00019501-200502000-00005","article-title":"Right ventricular failure following cardiac surgery.","volume":"16","author":"Vlahakes","year":"2005","journal-title":"Coron Artery Dis"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/00000542-200206000-00034","article-title":"Inhaled alternatives to nitric oxide.","volume":"96","author":"Lowson","year":"2002","journal-title":"Anesthesiology"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/00000539-200112000-00018","article-title":"The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.","volume":"93","author":"Haraldsson s","year":"2001","journal-title":"Anesth Analg"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtcvs.2004.09.011","article-title":"Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass.","volume":"130","author":"Lamarche","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/BF03021608","article-title":"Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates.","volume":"52","author":"Sablotzki","year":"2005","journal-title":"Can J Anaesth"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1089253206294400","article-title":"Inhaled milrinone: a new alternative in cardiac surgery?","volume":"10","author":"Denault","year":"2006","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejcts.2007.02.019","article-title":"Preliminary experience with inhaled milrinone in cardiac surgery.","volume":"31","author":"Lamarche","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.jvca.2012.10.017","article-title":"Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.","volume":"28","author":"St-Pierre","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jvca.2014.06.012","article-title":"Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension.","volume":"29","author":"Laflamme","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.","volume":"26","author":"Bradburn","year":"2007","journal-title":"Stat Med"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0003-4975(97)01307-6","article-title":"Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension.","volume":"65","author":"Argenziano","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1053-0770(00)90048-X","article-title":"A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients.","volume":"14","author":"Solina","year":"2000","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1067\/mtc.2003.107","article-title":"Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.","volume":"125","author":"Hach\u00e9","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.0886-0440.2005.200383w.x","article-title":"Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.","volume":"20","author":"Fattouch","year":"2005","journal-title":"J Card Surg"},{"key":"R31-20230812","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2459\/01.JCM.0000203850.97890.fe","article-title":"Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.","volume":"7","author":"Fattouch","year":"2006","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R32-20230812","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1399-6576.2007.01476.x","article-title":"Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.","volume":"52","author":"Rex","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"R33-20230812","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12325-009-0019-4","article-title":"Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.","volume":"26","author":"Wang","year":"2009","journal-title":"Adv Ther"},{"key":"R34-20230812","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2010.11.030","article-title":"Comparison of inhaled nitric oxide versus oxygen on hemodynamics in patients with mitral stenosis and severe pulmonary hypertension after mitral valve surgery.","volume":"107","author":"Fernandes","year":"2011","journal-title":"Am J Cardiol"},{"key":"R35-20230812","first-page":"192","article-title":"Pilot randomized controlled trial of inhaled milrinone in high-risk cardiac surgical patients.","volume":"4","author":"Denault","year":"2014","journal-title":"Surgery: Current Research"},{"key":"R36-20230812","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12630-016-0709-8","article-title":"A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.","volume":"63","author":"Denault","year":"2016","journal-title":"Can J Anaesth"},{"key":"R37-20230812","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"key":"R38-20230812","first-page":"436","article-title":"Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.","volume":"14","author":"Kieler-Jensen","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"R39-20230812","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1010-7940(96)80360-5","article-title":"A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation.","volume":"10","author":"Pagano","year":"1996","journal-title":"Eur J Cardiothorac Surg"},{"key":"R40-20230812","first-page":"1108","article-title":"Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.","volume":"89","author":"Schmid","year":"1999","journal-title":"Anesth Analg"},{"key":"R41-20230812","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00000539-200003000-00005","article-title":"Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation.","volume":"90","author":"Rajek","year":"2000","journal-title":"Anesth Analg"},{"key":"R42-20230812","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S1053-2498(01)00320-5","article-title":"The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.","volume":"20","author":"Weston","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R43-20230812","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.healun.2004.04.016","article-title":"Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.","volume":"24","author":"Radovancevic","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R44-20230812","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","article-title":"Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.","volume":"127","author":"De Wet","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R45-20230812","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1378\/chest.114.3.780","article-title":"Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.","volume":"114","author":"Haraldsson","year":"1998","journal-title":"Chest"},{"key":"R46-20230812","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S1010-7940(02)00488-8","article-title":"Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.","volume":"22","author":"Sablotzki","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"R47-20230812","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1067\/mtc.2003.49","article-title":"First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.","volume":"125","author":"Sablotzki","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R48-20230812","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.125.2.580","article-title":"Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.","volume":"125","author":"Leuchte","year":"2004","journal-title":"Chest"},{"key":"R49-20230812","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.jvca.2007.10.015","article-title":"Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial.","volume":"22","author":"Winterhalter","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R50-20230812","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jtcvs.2009.04.063","article-title":"A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.","volume":"138","author":"Khan","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R51-20230812","first-page":"38","article-title":"Comparison of hemodynamic effects of inhaled milrinone and inhaled prostacyclin after adult cardiac surgery.","volume":"6","author":"Hegazy","year":"2010","journal-title":"J Appl Sci Res"},{"key":"R52-20230812","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1053-0770(96)80047-4","article-title":"Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study.","volume":"10","author":"Haraldsson","year":"1996","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R53-20230812","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4236\/wjcs.2011.12004","article-title":"Fluid overload after coronary artery bypass grafting surgery increases the incidence of post-operative complications.","volume":"1","author":"Morin","year":"2011","journal-title":"World J Cardiovasc Surg"},{"key":"R54-20230812","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cjca.2016.08.012","article-title":"Extracardiac signs of fluid overload in the critically ill cardiac patient: a focused evaluation using bedside ultrasound.","volume":"33","author":"Beaubien-Souligny","year":"2017","journal-title":"Can J Cardiol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201708000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:24:25Z","timestamp":1786112665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201708000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000002138","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}